
The Telangana Drugs Control Administration found rule violations at 43 medical shops during a statewide enforcement drive against weight-loss medicines, Siasat.com reports. Officials inspected pharmacies on Friday, August 14, focusing on drugs…
The Telangana Drugs Control Administration found rule violations at 43 medical shops during a statewide enforcement drive against weight-loss medicines, Siasat.com reports. Officials inspected pharmacies on Friday, August 14, focusing on drugs containing Tirzepatide and Semaglutide, including Mounjaro, Ozempic, Wegovy and Rybelsus.

The checks also covered generic Semaglutide products and sought to detect spurious or counterfeit batches. The DCA examined whether pharmacies followed drug-sale rules and said further action would be taken against shops found violating them. The operation comes as demand rises for these medicines for weight management, increasing scrutiny of unauthorised sales and counterfeit products.

The lazy narrative is that every weight-loss injection sold through a pharmacy is automatically fake, while the opposite claim treats rising demand as proof that access needs no checks. Neither follows from this inspection. The key distinction is between genuine medicines sold under valid prescriptions and counterfeit or unauthorised products. The DCA should publish the nature of the violations and the number of counterfeit batches found. That evidence will show whether this was mainly a compliance issue or a wider safety threat.
Source: siasat.com
This story was synthesised by AI from the source linked above.